{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment]
RxNorm concept 1301696, branded pack (bpck). Prescribable name: Ultravate X Topical Ointment Pack.
- RxCUI
- 1301696
- Term type
- Branded pack (BPCK)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1301696 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Ultravate X Ointment Pack; {1 (1.8 OZ) (halobetasol propionate 0.05 % Topical Ointment) / 1 (8 OZ) (lactic acid 10 % Topical Cream) } Pack [Ultravate X Ointment]
Related concepts
- lactic acid 100 MG/ML Topical Cream (SCD, contains)
- halobetasol propionate 0.0005 MG/MG Topical Ointment (SCD, contains)
- Pack (DF, has dose form)
- {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack (GPCK, tradename of)
Linked data
NDCs
- 10631011901
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1301696 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1301696 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1301696. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.